| CORPORATE FINANCE |
July / August
2003 |
JV ON THE ROCKS
Without plenty of attention and TLC,
a joint venture may well run aground.
By Roy Harris
Trite as it may sound, a joint venture
really is like a marriage. For both, good communication between
partners is essential. Goals should be mutually agreed on.
And a little passion helps. As for the darker side of the
matrimonial comparison, many ventures, too, succumb to real-world
temptations. Further, even if they don't end outright in divorce
(corporate-style), JVs often drag through years in an unproductive
state.
There's also a familiar ring to the reasons
experts give for ventures failing or underperforming. Sometimes
ventures just slide by for a while on good feelings from the
wedding. "Many joint ventures have an initial endowment of
independence from the parents, but then neither parent exercises
the control they would exercise if the venture were an individual
business unit," says David Ernst, leader of McKinsey & Co.'s
global alliance practice.
And in general, corporate partners simply
do too little prenuptial planning. "Companies tend to be cavalier
about alliances, and think of them as no big deal," says Harbir
Singh, a management professor and director of the strategic
alliance program at the University of Pennsylvania's Wharton
School. A 2001 study he co-authored of 1,572 strategic alliances
showed that while ventures are an increasingly popular way
for companies to grow revenues, almost half fail.
There is much to be learned, though, from
companies that understand the perils of venturing, and govern
alliances with discipline and the desire to measure venture
performance properly. The high level of planning that goes
into Merck & Co's alliance structure, for example, assures
that good decision-making "kind of cascades," says executive
vice president and CFO Judy Lewent, who has strung together
successful drug ventures with Johnson & Johnson, AstraZeneca,
Schering-Plough, and other firms. "As you think through the
structuring of a joint venture, the structure enables the
alignment of the partners to the best degree possible." Merck
wants the venture to be "as close to a wholly owned subsidiary
as possible," says Lewent, and that requires "the right kinds
of performance measurements."
The Unexamined Life
Inattention to measurement, however, seems
endemic in most venturing. McKinsey, which counts itself something
of a marriage counselor for troubled ventures, sees poor use
of metrics at the root of JV problems. In a presentation entitled
"Measuring Alliance Performance: What CFOs Should Do to Avoid
Job-Threatening Surprises," McKinsey partner Ernst recently
cited a 1999 Andersen Consulting survey showing that only
11 percent of alliance partners believe they have sufficient
performance measurements in place. And a surprising 49 percent
declared they had "essentially no performance measurements
in place."
What's more, many agreements detailing
the governance plan for JVs "specify pretty low levels at
which parent or board approval is required for individual
decisions. So from the outside, it looks like the board should
have control," says Ernst. The problem, though, is that the
partners "tend to be invasive" and override board control
"on individual expenditures or contracts that generate financial
risk," he says. "That means risk management is on a very ad
hoc basis."
By signing risk-sharing agreements and
then inadequately monitoring performance, joint-venture partners
are asking for trouble. Ernst lists such venture-related damage
as earnings restatements caused by misrepresented venture
revenues, discovery of hidden liabilities, and costs from
duplicative staff or other inefficiencies. Poorly designed
formulas for transfer-pricing structures can multiply costs
quickly. And often the partnering companies have no organizational
structure to fix things.
"Many ventures simply lack a challenge
process," says Ernst. "The analogy would be a business unit
of a corporation that reports to a board but has no intermediate
authority." For such ventures, he suggests that a partner's
CFO "play the role of challenge agent," or that a group be
appointed to "aggressively set targets, ask probing questions,
and press for more performance." More broadly, Ernst suggests
auditing the portfolio of alliances to see which ones are
in need of restructuring.
Correcting underperformance problems
could add at least US$1 billion in shareholder value to Corporate
America, according to McKinsey. And the study co-authored
by Wharton's Singh also found significantly higher stock-market
prices accruing to companies with disciplined alliance-management
processes. The gains after alliance announcements at those
companies, in fact, add an average of US$75 million to market
capitalization, he says, compared with $20 million for nondisciplined
companies..
Cultural Factors
Sometimes JV issues run deeper than matters
of pure finance. When Delta Air Lines created an Atlanta-based
air-cargo venture with Air France and Korean Air in November
2001, the partners set up a nine-member board to oversee airline-performance
measures like freight sales and market share, along with indicators
on the operations-support side, such as call-center performance
and customer acceptance. The board meets quarterly, so partners
can keep tabs on the venture's progress.
The venture expected to encounter challenges
from bringing together airline employees who are from different
countries and who speak different languages. And it prepared
for them. "Part of our mission was to define a new culture,
something that people would identify with in this company,"
says venture CEO Bernard Frattini. Also, the drive to create
a single corporate structure out of three diverse airlines
"was quite tough, and we had to change the business plan a
few times" to reflect lessons learned. But customers "are
now looking at the venture as one company," he says, rather
than trying to keep lines of communication open with their
previous contacts. And morale is high.
Differences cropped up in accounting as
well, although most seemed minor. "Delta called forecasts
the 'revised plan,'" notes Frattini. And the venture had to
redefine such measures as net and gross revenue, which partner
airlines calculated differently. The partners sought to use
economies of scale to increase revenue beyond what the three
airlines would have produced before. Frattini would like the
venture's scale to be boosted even more, by the addition of
the two other Delta SkyTeam passenger-airline alliance partnersÑAlitalia
and Aeromexico, which have chosen so far not to participate
in the US cargo venture. Adding another partner "will be a
big signal that we have succeeded," says Frattini. (CSA Czech
Airlines recently joined the alliance.)
Merck's Prescription
Merck likes to keep its JVs simple.
"The most successful structures I've seen are 50/50 ventures,
with no bells and no whistles, where the partners are in it
together," says CFO Lewent. The governance structure for its
JVs generally involves a board and an executive committee,
which Lewent usually co-chairs. "The [executive committee]
has a broad charter, but the most important thing is that
we talk frequently, and when we meet, we have the head of
the venture with us," she says. Performance grids are set
out for each venture, "with very clear expectations of what
success means in a given year," says Lewent. That covers revenue
expectations, cash flow, and measures in such strategic areas
as research-and-development productivityÑa particularly important
metric for Merck's five-year-old animal-health venture, operated
with Aventis. At Merck, Lewent explains, venturing processes
also reflect "the relative importance of a JV at different
times in its development," including when the JV might end,
under a scenario that is part of the structure designed into
the original agreement. When a venture with DuPont Pharma
ended in 1998, wrapping up an alliance that Merck counts as
a success, it did bring with it one good lesson in venture
management. By creating finite horizons for a decision on
whether to continue a venture, the DuPont and Merck parties
"hardwired" a deadline that changed the way the parties performed.
"I personally think that mechanism has some disadvantages
to it. It's a problematic dynamic," says Lewent. Basically,
the wind-down period to the end of the venture can encourage
people to think more about their own benefit at the conclusion
of the enterprise and less about the benefit to the organizationÑa
phenomenon that happens less when the plans for ending a venture
are based more on performance and the changing wishes of management.
In later ventures, she notes, Merck established more flexible
horizons for decisions that could mark the potential end of
partnerships. The decisions, she says, now reflect "a shared
understanding of what success is." 
|